Clinical Research

Investigator Initiated Research Submission

Start Proposal

Thank you for your interest in partnering with Endologix on your Investigator-Initiated Research. Physician collaboration is central to Endologix’s mission, fueling innovation that transforms patient care.

Please complete the form below and upload the required submission documents (i.e. research synopsis, budget, timelines and milestones, and curriculum vitae and/or medical license).

Each submission is evaluated consistently for educational and scientific merit, potential to improve patient outcomes, compliance with applicable guidelines, and budget availability.

Investigator Initiated Research

Investigator Contact Information

Research Information

Maximum file size: 10MB

Frequently Asked Questions

IIR is a research study initiated and conducted by an independent investigator, where the investigator assumes responsibility for the design, conduct, management and regulatory oversight of the study.

No. Requests involving investigational products or devices for off-label indications are not accepted. Only studies for approved devices and on-label indications will be considered for IIR submissions.

Licensed healthcare professionals, clinical researchers, or institutions with experience in conducting research and access to the target patient population may submit a request.

We aim to provide a decision on submitted proposals in one to three months, which provides time for collaborative communication.

If there are further questions or issues with the online submission form, please contact Endologix at iir@endologix.com

Yes, Investigator Initiated Research requests will be considered from all countries where the product of interest is commercially available.

Each submission is reviewed for scientific merit and feasibility, investigator qualifications, alignment with company research strategy, budget justification, as well as ethical and regulatory compliance.

Upon receipt of all required submission documents, the Endologix review committee will review and either approve, deny, or request clarification before making a final decision.

For preliminary ideas, the committee may provide feedback indicating general interest; however, this does not guarantee approval of a full submission.

Although denial of an application does not mean that the proposed research lacks value, we highly encourage Investigators to pursue other sources of funding and welcome Investigators to reapply with a new or revised study idea.

An agreement is executed between Endologix and the Investigator/Institution, including a budget with payment milestones. The Investigator must comply with all regulatory requirements, report any adverse events, and submit periodic progress reports per the agreement.

We encourage Investigators to publish results in peer-reviewed journals or present at relevant conferences. All publications must comply with applicable transparency and authorship guidelines, as agreed upon in the contract.

Generally, the Investigator owns the data. Endologix, however, may request access to de-identified data for regulatory or strategic use, as agreed upon in the contract.

Please submit the electronic form and attach all required documents:

  • Research synopsis
  • Itemized budget: include any resources such as internal and external products, and any alternate funding sources, as applicable.
  • Timelines and key milestones
  • CV and/or medical license
  • Any additional supporting documents: This may include monitoring plan, data management plan, informed consent, record retention, research team contact list, logistical information, laboratory and radiological information, adverse events reporting, publications, etc.